We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses. MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of...
Completed $5.8 million private placement financing at 25% premium Upcoming presentation of agenT-797 in severe respiratory distress at the American Thoracic Society (ATS)AACR presentation reported...
Financing of $5.8 Million at a 25% premium will help advance the clinical development of MiNK-215, an armored-FAP-CAR-iNKTGKCC, LLC joins as a new investor with Katie Chudnovsky appointed as a...
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0263 | -2.65656565657 | 0.99 | 1.02 | 0.93 | 60099 | 0.94728093 | CS |
4 | -0.0263 | -2.65656565657 | 0.99 | 1.3 | 0.86 | 355851 | 0.99475291 | CS |
12 | 0.0037 | 0.385416666667 | 0.96 | 1.9 | 0.78 | 199483 | 1.09478633 | CS |
26 | -0.0863 | -8.21904761905 | 1.05 | 1.9 | 0.75 | 121751 | 1.06059334 | CS |
52 | -1.0363 | -51.815 | 2 | 3.34 | 0.75 | 98138 | 1.3655679 | CS |
156 | -11.0763 | -91.9958471761 | 12.04 | 22.155 | 0.75 | 119540 | 2.88948329 | CS |
260 | -11.0763 | -91.9958471761 | 12.04 | 22.155 | 0.75 | 119540 | 2.88948329 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions